NRX Pharmaceuticals, Inc.
NRX Pharmaceuticals, Inc. (NRXP) is a publicly traded company in the Unknown sector. Across all available filings, 12 corporate insiders have executed 62 transactions totaling $9.8M, demonstrating a bullish sentiment with $4.5M in net insider flow. The most recent transaction on Aug 30, 2023 involved a purchase of 70,000 shares valued at $20.3K.
NRXP Insider Activity Summary
Who Is Buying NRXP Stock?
No significant insider buying has been recorded for NRXP in the recent period.
Who Is Selling NRXP Stock?
No significant insider selling has been recorded for NRXP in the recent period.
Is NRX Pharmaceuticals, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for NRXP is bullish with an Insider Alignment Score of 73/100 and a net flow of $4.5M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
NRXP Frequently Asked Questions
Understanding NRXP Insider Activity
Insider trading at NRX Pharmaceuticals, Inc. (NRXP) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 12 insiders are actively trading NRXP stock, having executed 62 transactions in the past 90 days. The most active insider is Jonathan C. Javitt (Executive), who has made 9 transactions totaling $6.4M.
Related Tools
Track NRX Pharmaceuticals, Inc. Insider Activity
Get notified when executives and directors at NRXP file new Form 4 transactions